Skip to content

AXCOFARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

AXCOFARMA

BE 0889.949.363
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€30,886
2024 · €10,775+€20,112
Equity
€47,483
2024 · €47,483
Cash
€99,451
2024 · €255,603-€156,151
Balance sheet total
€489,172
2024 · €383,144+€106,028

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€251,964

    up €251,964 (+3304.6%), from €7,625 to €259,589

    of which Land and buildings: +€253,545

  • Cash -€156,151

    down €156,151 (-61.1%), from €255,603 to €99,451

    mainly Investment in fixed assets (net) (-€260,000) and Trade debts (-€34,704)

  • Stocks and contracts +€7,368

    up €7,368 (+10.9%), from €67,362 to €74,730

Equity and liabilities
  • Other debts +€140,396

    up €140,396 (+56.1%), from €250,411 to €390,807

  • Trade debts -€34,704

    down €34,704 (-52.3%), from €66,371 to €31,667

Income statement
  • Gross operating margin +€57,191

    up €57,191 (+68.0%), from €84,090 to €141,281

  • Other operating charges +€31,524

    up €31,524 (+6224.1%), from €506 to €32,031

  • Depreciation +€5,945

    up €5,945 (+284.2%), from €2,092 to €8,036

  • Taxes -€2,165

    down €2,165 (-57.0%), from €3,798 to €1,633

  • Staff costs +€1,565

    up €1,565 (+2.4%), from €65,931 to €67,496

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €10,775
Gross operating margin +€57,191
Staff costs -€1,565
Depreciation -€5,945
Other operating charges -€31,524
Financial income +€121
Financial charges -€331
Taxes +€2,165
Result 2025 €30,886

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€134,735
Investment -€260,000
Financing -€30,886
Cash 2024 €255,603
Net result for the year +€30,886
Depreciation +€8,036
Stocks and contracts -€7,368
Receivables within one year -€2,926
Deferred charges and accrued income +€78
Trade debts -€34,704
Tax, wage and social debts +€2,417
Other debts +€140,396
Accrued charges and deferred income -€2,081
Investment in fixed assets (net) -€260,000
Contributions, distributions and other -€30,886
Cash 2025 €99,451
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €383,144 €489,172 +€106,028 +27.7%
Fixed assets 21/28 €7,625 €259,589 +€251,964 +3304.6%
Tangible fixed assets 22/27 €7,625 €259,589 +€251,964 +3304.6%
Land and buildings 22 €784 €254,329 +€253,545 +32330.0%
Plant, machinery and equipment 23 €2,060 €976 -€1,084 -52.6%
Furniture and vehicles 24 €4,780 €4,284 -€496 -10.4%
Current assets 29/58 €375,519 €229,584 -€145,935 -38.9%
Stocks and contracts in progress 3 €67,362 €74,730 +€7,368 +10.9%
Stocks 30/36 €67,362 €74,730 +€7,368 +10.9%
Amounts receivable within one year 40/41 €46,951 €49,877 +€2,926 +6.2%
Trade receivables 40 €44,651 €49,371 +€4,720 +10.6%
Other amounts receivable 41 €2,299 €505 -€1,794 -78.0%
Cash at bank and in hand 54/58 €255,603 €99,451 -€156,151 -61.1%
Deferred charges and accrued income 490/1 €5,604 €5,526 -€78 -1.4%
Total equity and liabilities 10/49 €383,144 €489,172 +€106,028 +27.7%
Equity 10/15 €47,483 €47,483 = 0.0%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €35,083 €35,083 = 0.0%
Distributable reserves 133 €35,083 €35,083 = 0.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €335,661 €441,690 +€106,028 +31.6%
Amounts payable within one year 42/48 €331,212 €439,321 +€108,109 +32.6%
Trade debts 44 €66,371 €31,667 -€34,704 -52.3%
Suppliers 440/4 €66,371 €31,667 -€34,704 -52.3%
Taxes, remuneration and social security 45 €14,430 €16,847 +€2,417 +16.8%
Taxes 450/3 €1,574 €3,722 +€2,148 +136.4%
Remuneration and social security 454/9 €12,855 €13,125 +€270 +2.1%
Other amounts payable 47/48 €250,411 €390,807 +€140,396 +56.1%
Accrued charges and deferred income 492/3 €4,449 €2,369 -€2,081 -46.8%
Remuneration, social security and pensions 62 €65,931 €67,496 +€1,565 +2.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,092 €8,036 +€5,945 +284.2%
Other operating charges 640/8 €506 €32,031 +€31,524 +6224.1%
Gross operating margin 9900 €84,090 €141,281 +€57,191 +68.0%
Operating profit (loss) 9901 €15,561 €33,718 +€18,156 +116.7%
Financial income 75/76B €323 €444 +€121 +37.5%
Recurring financial income 75 €323 €444 +€121 +37.5%
Financial charges 65/66B €1,311 €1,643 +€331 +25.3%
Recurring financial charges 65 €1,311 €1,643 +€331 +25.3%
Profit (loss) for the period before taxes 9903 €14,573 €32,519 +€17,946 +123.1%
Income taxes 67/77 €3,798 €1,633 -€2,165 -57.0%
Profit (loss) for the period 9904 €10,775 €30,886 +€20,112 +186.7%
Profit (loss) for the period to be appropriated 9905 €10,775 €30,886 +€20,112 +186.7%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.